Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2024

Open Access 01-12-2024 | Heart Failure | Research

Development and validation of a novel combinatorial nomogram model to predict in-hospital deaths in heart failure patients

Authors: Dabei Cai, Qianwen Chen, Xiaobo Mu, Tingting Xiao, Qingqing Gu, Yu Wang, Yuan Ji, Ling Sun, Jun Wei, Qingjie Wang

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Background

The purpose of this study was to develop a Nomogram model to identify the risk of all-cause mortality during hospitalization in patients with heart failure (HF).

Methods

HF patients who had been registered in the Medical Information Mart for Intensive Care (MIMIC) III and IV databases were included. The primary outcome was the occurrence of all-cause mortality during hospitalization. Two Logistic Regression models (LR1 and LR2) were developed to predict in-hospital death for HF patients from the MIMIC-IV database. The MIMIC-III database were used for model validation. The area under the receiver operating characteristic curve (AUC) was used to compare the discrimination of each model. Calibration curve was used to assess the fit of each developed models. Decision curve analysis (DCA) was used to estimate the net benefit of the predictive model.

Results

A total of 16,908 HF patients were finally enrolled through screening, of whom 2,283 (13.5%) presented with in-hospital death. Totally, 48 variables were included and analyzed in the univariate and multifactorial regression analysis. The AUCs for the LR1 and LR2 models in the test cohort were 0.751 (95% CI: 0.735∼0.767) and 0.766 (95% CI: 0.751–0.781), respectively. Both LR models performed well in the calibration curve and DCA process. Nomogram and online risk assessment system were used as visualization of predictive models.

Conclusion

A new risk prediction tool and an online risk assessment system were developed to predict mortality in HF patients, which performed well and might be used to guide clinical practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tripoliti EE, Papadopoulos TG, Karanasiou GS, et al. Heart failure: diagnosis, severity estimation and prediction of adverse events through machine learning techniques. Comput Struct Biotechnol J. 2017;15:26–47.PubMedCrossRef Tripoliti EE, Papadopoulos TG, Karanasiou GS, et al. Heart failure: diagnosis, severity estimation and prediction of adverse events through machine learning techniques. Comput Struct Biotechnol J. 2017;15:26–47.PubMedCrossRef
2.
go back to reference Yin J, Lu X, Qian Z, et al. New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure. Theranostics. 2019;9(14):4019–29.PubMedPubMedCentralCrossRef Yin J, Lu X, Qian Z, et al. New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure. Theranostics. 2019;9(14):4019–29.PubMedPubMedCentralCrossRef
4.
go back to reference Meyer S, Brouwers FP, Voors AA, et al. Sex differences in new-onset heart failure. Clin Res Cardiol. 2015;104(4):342–50.PubMedCrossRef Meyer S, Brouwers FP, Voors AA, et al. Sex differences in new-onset heart failure. Clin Res Cardiol. 2015;104(4):342–50.PubMedCrossRef
5.
go back to reference Brouwers FP, de Boer RA, van der Harst P, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424–31.PubMedCrossRef Brouwers FP, de Boer RA, van der Harst P, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424–31.PubMedCrossRef
6.
go back to reference Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart failure society of America. Circulation. 2017;136(6):e137–61.PubMedCrossRef Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart failure society of America. Circulation. 2017;136(6):e137–61.PubMedCrossRef
7.
go back to reference Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart failure society of America. J Card Fail. 2017;23(8):628–51.PubMedCrossRef Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart failure society of America. J Card Fail. 2017;23(8):628–51.PubMedCrossRef
8.
go back to reference Metra M, Lucioli P. Corrigendum to ‘Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015’ [Eur J Heart Fail 2019;21:1329–1337]. Eur J Heart Fail. 2020;22(4):759.PubMedCrossRef Metra M, Lucioli P. Corrigendum to ‘Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015’ [Eur J Heart Fail 2019;21:1329–1337]. Eur J Heart Fail. 2020;22(4):759.PubMedCrossRef
9.
go back to reference van Riet EE, Hoes AW, Wagenaar KP, et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016;18(3):242–52.PubMedCrossRef van Riet EE, Hoes AW, Wagenaar KP, et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016;18(3):242–52.PubMedCrossRef
10.
go back to reference Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: A report from the American heart association. Circulation. 2018;137(12):e67–492.PubMedCrossRef Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: A report from the American heart association. Circulation. 2018;137(12):e67–492.PubMedCrossRef
11.
12.
go back to reference Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25.PubMedPubMedCentralCrossRef Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25.PubMedPubMedCentralCrossRef
13.
go back to reference Çavuşoğlu Y, Altay H, Aras D, et al. Cost-of-disease of heart failure in Turkey: a Delphi panel-based analysis of direct and indirect costs. Balkan Med J. 2022;39(4):282–9.PubMedPubMedCentralCrossRef Çavuşoğlu Y, Altay H, Aras D, et al. Cost-of-disease of heart failure in Turkey: a Delphi panel-based analysis of direct and indirect costs. Balkan Med J. 2022;39(4):282–9.PubMedPubMedCentralCrossRef
15.
go back to reference Tian S, Sun S, Mao W, et al. Development and validation of prognostic nomogram for young patients with kidney cancer. Int J Gen Med. 2021;14:5091–103.PubMedPubMedCentralCrossRef Tian S, Sun S, Mao W, et al. Development and validation of prognostic nomogram for young patients with kidney cancer. Int J Gen Med. 2021;14:5091–103.PubMedPubMedCentralCrossRef
16.
go back to reference Yang H, Zeng M, Cao S, et al. Nomograms predicting prognosis for locally advanced hypopharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2022;279(6):3041–52.PubMedCrossRef Yang H, Zeng M, Cao S, et al. Nomograms predicting prognosis for locally advanced hypopharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2022;279(6):3041–52.PubMedCrossRef
17.
go back to reference Rocco B, Sighinolfi MC, Sandri M, et al. A novel nomogram for predicting ECE of prostate cancer. BJU Int. 2018;122(6):916–8.PubMedCrossRef Rocco B, Sighinolfi MC, Sandri M, et al. A novel nomogram for predicting ECE of prostate cancer. BJU Int. 2018;122(6):916–8.PubMedCrossRef
18.
go back to reference Wang Q, Qian W, Sun Z, et al. Nomograms based on pre-operative parametric for prediction of short-term mortality in acute myocardial infarction patients treated invasively. Aging (Albany NY). 2020;13(2):2184–97.PubMedCrossRef Wang Q, Qian W, Sun Z, et al. Nomograms based on pre-operative parametric for prediction of short-term mortality in acute myocardial infarction patients treated invasively. Aging (Albany NY). 2020;13(2):2184–97.PubMedCrossRef
20.
go back to reference Wu J, Zhang H, Li L, et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond). 2020;40(7):301–12.PubMedCrossRef Wu J, Zhang H, Li L, et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond). 2020;40(7):301–12.PubMedCrossRef
21.
go back to reference Hong X, Li D, Yang X, et al. Nomogram for predicting the severity of coronary artery disease in young adults ≤45 years of age with acute coronary syndrome. CVIA. 2022;7(1):e994. Hong X, Li D, Yang X, et al. Nomogram for predicting the severity of coronary artery disease in young adults ≤45 years of age with acute coronary syndrome. CVIA. 2022;7(1):e994.
23.
go back to reference Liu Q, Zheng HL, Wu MM, et al. Association between lactate-to-albumin ratio and 28-days all-cause mortality in patients with acute pancreatitis: a retrospective analysis of the MIMIC-IV database. Front Immunol. 2022;13:1076121.PubMedPubMedCentralCrossRef Liu Q, Zheng HL, Wu MM, et al. Association between lactate-to-albumin ratio and 28-days all-cause mortality in patients with acute pancreatitis: a retrospective analysis of the MIMIC-IV database. Front Immunol. 2022;13:1076121.PubMedPubMedCentralCrossRef
24.
go back to reference Han YQ, Yan L, Zhang L, et al. Red blood cell distribution width provides additional prognostic value beyond severity scores in adult critical illness. Clin Chim Acta. 2019;498:62–7.PubMedCrossRef Han YQ, Yan L, Zhang L, et al. Red blood cell distribution width provides additional prognostic value beyond severity scores in adult critical illness. Clin Chim Acta. 2019;498:62–7.PubMedCrossRef
25.
go back to reference Cai D, Xiao T, Zou A, et al. Predicting acute kidney injury risk in acute myocardial infarction patients: an artificial intelligence model using medical information mart for intensive care databases. Front Cardiovasc Med. 2022;9:964894.PubMedPubMedCentralCrossRef Cai D, Xiao T, Zou A, et al. Predicting acute kidney injury risk in acute myocardial infarction patients: an artificial intelligence model using medical information mart for intensive care databases. Front Cardiovasc Med. 2022;9:964894.PubMedPubMedCentralCrossRef
27.
go back to reference Park SY. Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg. 2018;155(4):1793.PubMedCrossRef Park SY. Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg. 2018;155(4):1793.PubMedCrossRef
28.
go back to reference Austin PC, Harrell FE Jr, van Klaveren D. Graphical calibration curves and the integrated calibration index (ICI) for survival models. Stat Med. 2020;39(21):2714–42.PubMedPubMedCentralCrossRef Austin PC, Harrell FE Jr, van Klaveren D. Graphical calibration curves and the integrated calibration index (ICI) for survival models. Stat Med. 2020;39(21):2714–42.PubMedPubMedCentralCrossRef
30.
go back to reference Kerr KF, Brown MD, Zhu K, et al. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol. 2016;34(21):2534–40.PubMedPubMedCentralCrossRef Kerr KF, Brown MD, Zhu K, et al. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol. 2016;34(21):2534–40.PubMedPubMedCentralCrossRef
31.
go back to reference Uno H, Tian L, Cai T, et al. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med. 2013;32(14):2430–42.PubMedCrossRef Uno H, Tian L, Cai T, et al. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med. 2013;32(14):2430–42.PubMedCrossRef
32.
go back to reference Pencina MJ, D’Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11–21.PubMedCrossRef Pencina MJ, D’Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11–21.PubMedCrossRef
33.
go back to reference Sun L, Zhou X, Jiang J, et al. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a retrospective observation study. PLoS One. 2018;13(5):e0197609.PubMedPubMedCentralCrossRef Sun L, Zhou X, Jiang J, et al. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a retrospective observation study. PLoS One. 2018;13(5):e0197609.PubMedPubMedCentralCrossRef
34.
go back to reference Fonarow GC, Adams KF Jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293(5):572–80.PubMedCrossRef Fonarow GC, Adams KF Jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293(5):572–80.PubMedCrossRef
35.
go back to reference Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008;52(5):347–56.PubMedCrossRef Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008;52(5):347–56.PubMedCrossRef
36.
go back to reference Peterson PN, Rumsfeld JS, Liang L, et al. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes. 2010;3(1):25–32.PubMedCrossRef Peterson PN, Rumsfeld JS, Liang L, et al. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes. 2010;3(1):25–32.PubMedCrossRef
37.
go back to reference Araiza-Garaygordobil D, Gopar-Nieto R, Martínez-Amezcua P, et al. Point-of-care lung ultrasound predicts in-hospital mortality in acute heart failure. QJM. 2021;114(2):111–6.PubMedCrossRef Araiza-Garaygordobil D, Gopar-Nieto R, Martínez-Amezcua P, et al. Point-of-care lung ultrasound predicts in-hospital mortality in acute heart failure. QJM. 2021;114(2):111–6.PubMedCrossRef
38.
go back to reference Maggioni AP, Orso F, Calabria S, et al. The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database. Eur J Heart Fail. 2016;18(4):402–10.PubMedCrossRef Maggioni AP, Orso F, Calabria S, et al. The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database. Eur J Heart Fail. 2016;18(4):402–10.PubMedCrossRef
39.
go back to reference Khan T, Awadalla AF. Survival rates in elderly patients with heart failure. Eur J Heart Fail. 2020;22(3):566.PubMedCrossRef Khan T, Awadalla AF. Survival rates in elderly patients with heart failure. Eur J Heart Fail. 2020;22(3):566.PubMedCrossRef
40.
go back to reference Chioncel O, Ambrosy AP, Filipescu D, et al. Patterns of intensive care unit admissions in patients hospitalized for heart failure: insights from the RO-AHFS registry. J Cardiovasc Med (Hagerstown). 2015;16(5):331–40.PubMedCrossRef Chioncel O, Ambrosy AP, Filipescu D, et al. Patterns of intensive care unit admissions in patients hospitalized for heart failure: insights from the RO-AHFS registry. J Cardiovasc Med (Hagerstown). 2015;16(5):331–40.PubMedCrossRef
41.
go back to reference Follath F, Yilmaz MB, Delgado JF, et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). Intensive Care Med. 2011;37(4):619–26.PubMedCrossRef Follath F, Yilmaz MB, Delgado JF, et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). Intensive Care Med. 2011;37(4):619–26.PubMedCrossRef
42.
go back to reference Cooper LB, Mentz RJ, Gallup D, et al. Serum bicarbonate in acute heart failure: relationship to treatment strategies and clinical outcomes. J Card Fail. 2016;22(9):738–42.PubMedPubMedCentralCrossRef Cooper LB, Mentz RJ, Gallup D, et al. Serum bicarbonate in acute heart failure: relationship to treatment strategies and clinical outcomes. J Card Fail. 2016;22(9):738–42.PubMedPubMedCentralCrossRef
43.
go back to reference Adamopoulos C, Pitt B, Sui X, et al. Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study. Int J Cardiol. 2009;136(3):270–7.PubMedCrossRef Adamopoulos C, Pitt B, Sui X, et al. Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study. Int J Cardiol. 2009;136(3):270–7.PubMedCrossRef
44.
go back to reference Angkananard T, Anothaisintawee T, Eursiriwan S, et al. The association of serum magnesium and mortality outcomes in heart failure patients: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(50):e5406.PubMedCrossRef Angkananard T, Anothaisintawee T, Eursiriwan S, et al. The association of serum magnesium and mortality outcomes in heart failure patients: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(50):e5406.PubMedCrossRef
45.
go back to reference Naksuk N, Hu T, Krittanawong C, et al. Association of serum magnesium on mortality in patients admitted to the intensive cardiac care unit. Am J Med. 2017;130(2):229.e5–.e13.PubMedCrossRef Naksuk N, Hu T, Krittanawong C, et al. Association of serum magnesium on mortality in patients admitted to the intensive cardiac care unit. Am J Med. 2017;130(2):229.e5–.e13.PubMedCrossRef
46.
go back to reference Guo W, Peng C, Liu Q, et al. Association between base excess and mortality in patients with congestive heart failure. ESC Heart Fail. 2021;8(1):250–8.PubMedCrossRef Guo W, Peng C, Liu Q, et al. Association between base excess and mortality in patients with congestive heart failure. ESC Heart Fail. 2021;8(1):250–8.PubMedCrossRef
47.
go back to reference Nakano H, Nagai T, Honda Y, et al. Prognostic value of base excess as indicator of acid-base balance in acute heart failure. Eur Heart J Acute Cardiovasc Care. 2020;9(5):399–405.PubMedCrossRef Nakano H, Nagai T, Honda Y, et al. Prognostic value of base excess as indicator of acid-base balance in acute heart failure. Eur Heart J Acute Cardiovasc Care. 2020;9(5):399–405.PubMedCrossRef
48.
go back to reference Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112(17):2627–33.PubMedCrossRef Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112(17):2627–33.PubMedCrossRef
49.
go back to reference McGovern AP, de Lusignan S, van Vlymen J, et al. Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study. PLoS One. 2013;8(9):e74996.PubMedPubMedCentralCrossRef McGovern AP, de Lusignan S, van Vlymen J, et al. Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study. PLoS One. 2013;8(9):e74996.PubMedPubMedCentralCrossRef
50.
go back to reference Nikolaou M, Parissis J, Yilmaz MB, et al. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J. 2013;34(10):742–9.PubMedCrossRef Nikolaou M, Parissis J, Yilmaz MB, et al. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J. 2013;34(10):742–9.PubMedCrossRef
51.
go back to reference Wu AH, Levy WC, Welch KB, et al. Association between bilirubin and mode of death in severe systolic heart failure. Am J Cardiol. 2013;111(8):1192–7.PubMedCrossRef Wu AH, Levy WC, Welch KB, et al. Association between bilirubin and mode of death in severe systolic heart failure. Am J Cardiol. 2013;111(8):1192–7.PubMedCrossRef
52.
go back to reference Wang H, Jia Q, Shi J, et al. Prognostic value of serum bilirubin in patients with heart failure: a protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2021;100(22):e26180.PubMedCrossRef Wang H, Jia Q, Shi J, et al. Prognostic value of serum bilirubin in patients with heart failure: a protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2021;100(22):e26180.PubMedCrossRef
53.
go back to reference Lewis GA, Schelbert EB, Williams SG, et al. Biological phenotypes of heart failure with preserved ejection fraction. J Am Coll Cardiol. 2017;70(17):2186–200.PubMedCrossRef Lewis GA, Schelbert EB, Williams SG, et al. Biological phenotypes of heart failure with preserved ejection fraction. J Am Coll Cardiol. 2017;70(17):2186–200.PubMedCrossRef
54.
go back to reference Woolley RJ, Ceelen D, Ouwerkerk W, et al. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction. Eur J Heart Fail. 2021;23(6):983–91.PubMedCrossRef Woolley RJ, Ceelen D, Ouwerkerk W, et al. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction. Eur J Heart Fail. 2021;23(6):983–91.PubMedCrossRef
55.
go back to reference Peng S, Huang J, Liu X, et al. Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: a retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases. Front Cardiovasc Med. 2022;9:994359.PubMedPubMedCentralCrossRef Peng S, Huang J, Liu X, et al. Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: a retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases. Front Cardiovasc Med. 2022;9:994359.PubMedPubMedCentralCrossRef
56.
go back to reference Li J, Liu S, Hu Y, et al. Predicting mortality in intensive care unit patients with heart failure using an interpretable machine learning model: retrospective cohort study. J Med Internet Res. 2022;24(8):e38082.PubMedPubMedCentralCrossRef Li J, Liu S, Hu Y, et al. Predicting mortality in intensive care unit patients with heart failure using an interpretable machine learning model: retrospective cohort study. J Med Internet Res. 2022;24(8):e38082.PubMedPubMedCentralCrossRef
57.
go back to reference Ouwerkerk W, Tromp J, Jin X, et al. Heart failure with preserved ejection fraction diagnostic scores in an Asian population. Eur J Heart Fail. 2020;22(9):1737–9.PubMedCrossRef Ouwerkerk W, Tromp J, Jin X, et al. Heart failure with preserved ejection fraction diagnostic scores in an Asian population. Eur J Heart Fail. 2020;22(9):1737–9.PubMedCrossRef
58.
go back to reference Wong CM, Hawkins NM, Petrie MC, et al. Heart failure in younger patients: the meta-analysis Global Group in Chronic Heart Failure (MAGGIC). Eur Heart J. 2014;35(39):2714–21.PubMedCrossRef Wong CM, Hawkins NM, Petrie MC, et al. Heart failure in younger patients: the meta-analysis Global Group in Chronic Heart Failure (MAGGIC). Eur Heart J. 2014;35(39):2714–21.PubMedCrossRef
Metadata
Title
Development and validation of a novel combinatorial nomogram model to predict in-hospital deaths in heart failure patients
Authors
Dabei Cai
Qianwen Chen
Xiaobo Mu
Tingting Xiao
Qingqing Gu
Yu Wang
Yuan Ji
Ling Sun
Jun Wei
Qingjie Wang
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Heart Failure
Published in
BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-023-03683-0

Other articles of this Issue 1/2024

BMC Cardiovascular Disorders 1/2024 Go to the issue